検索
Virax Biolabs Group Ltd
VRAXウォッチリストに追加
2.500USD
+0.190+8.23%
終値 09-22 16:00（ET）
2.00M時価総額
損失額直近12ヶ月PER
Virax Biolabs Group Ltdについて 企業名
Virax Biolabs Group Limited is a biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. The Company is engaged in developing ViraxImmune with the intention of providing an immunology profiling platform that assesses each individual’s immune risk profile against global viral diseases as well as helping with the early diagnosis of post-viral syndromes associated with T cell exhaustion and chronic inflammation. Its product portfolio includes ViraxClear and ViraxVet. ViraxClear offers a range of accurate diagnostic testing kits and machines. ViraxVet offers various rapid and molecular tests for small animal veterinary diagnostics. The Company is initially focused on diseases associated with post-viral syndromes, including SARS-CoV-2, Human Papillomavirus (HPV), Malaria, Hepatitis B, and Herpes (HSV-1).
Virax Biolabs Group Ltd プロフィール
企業コードVRAX
会社名Virax Biolabs Group Ltd
上場日Jul 14, 2022
最高経営責任者「CEO」Foster (James)
従業員数19
証券種類Ordinary Share
決算期末Jul 14
本社所在地Biocity Glasgow
都市LONDON
証券取引所NASDAQ OMX - NASDAQ BASIC
国United Kingdom
郵便番号ML1 5UH
電話番号4402077887414
ウェブサイトhttps://www.viraxbiolabs.com
企業コードVRAX
上場日Jul 14, 2022
最高経営責任者「CEO」Foster (James)
Virax Biolabs Group Ltdの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. James Foster
Mr. James Foster
Chairman of the Board, Chief Executive Officer, Principal Accounting Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Principal Accounting Officer, Co-Founder
16.61K
+30.65%
Mr. James Foster
Mr. James Foster
Chairman of the Board, Chief Executive Officer, Principal Accounting Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Principal Accounting Officer, Co-Founder
16.61K
+30.65%
Mr. Evan Norton
Mr. Evan Norton
Independent Director
Independent Director
880.00
+30.34%
Mr. Evan Norton
Mr. Evan Norton
Independent Director
Independent Director
880.00
+30.34%
Mr. Nelson M. Haight
Mr. Nelson M. Haight
Independent Director
Independent Director
--
--
Dr. Nigel Mccracken, Ph.D.
Dr. Nigel Mccracken, Ph.D.
Chief Operating Officer, Director
Chief Operating Officer, Director
--
--
Dr. Iain Miller
Dr. Iain Miller
Independent Director
Independent Director
--
--
Mr. Nelson M. Haight
Mr. Nelson M. Haight
Independent Director
Independent Director
--
--
Dr. Nigel Mccracken, Ph.D.
Dr. Nigel Mccracken, Ph.D.
Chief Operating Officer, Director
Chief Operating Officer, Director
--
--
Dr. Iain Miller
Dr. Iain Miller
Independent Director
Independent Director
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. James Foster
Mr. James Foster
Chairman of the Board, Chief Executive Officer, Principal Accounting Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Principal Accounting Officer, Co-Founder
16.61K
+30.65%
Mr. James Foster
Mr. James Foster
Chairman of the Board, Chief Executive Officer, Principal Accounting Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Principal Accounting Officer, Co-Founder
16.61K
+30.65%
Mr. Evan Norton
Mr. Evan Norton
Independent Director
Independent Director
880.00
+30.34%
Mr. Evan Norton
Mr. Evan Norton
Independent Director
Independent Director
880.00
+30.34%
Mr. Nelson M. Haight
Mr. Nelson M. Haight
Independent Director
Independent Director
--
--
Dr. Nigel Mccracken, Ph.D.
Dr. Nigel Mccracken, Ph.D.
Chief Operating Officer, Director
Chief Operating Officer, Director
--
--
よくある質問
Virax Biolabs Group Ltdの上位5名の株主は誰ですか？
Virax Biolabs Group Ltdの上位5名の株主は以下のとおりです。Mr. James Foster
Virax Biolabs Group Ltd（VRAX）の株式を保有している機関の数はいくつですか？
2026Q1時点で、Virax Biolabs Group Ltdの株式を保有している機関は22社あり、保有株式の総市場価値は約851.39Kで、全体の4.27%を占めています。2025Q4と比較して、機関の持ち株は268600.00増加しています。